相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial†
E. Deutsch et al.
ANNALS OF ONCOLOGY (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma
Luis O. Olivatto et al.
CANCER (2013)
RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal
Lisa A. Kachnic et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: A propensity score analysis
Tina Dasgupta et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience
Kyung Hwan Kim et al.
RADIATION ONCOLOGY JOURNAL (2013)
EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?
A. Paliga et al.
BRITISH JOURNAL OF CANCER (2012)
Concurrent Chemotherapy and Intensity-modulated Radiation Therapy for Anal Carcinoma - Clinical Outcomes in a Large National Cancer Institute-designated Integrated Cancer Centre Network
S. G. DeFoe et al.
CLINICAL ONCOLOGY (2012)
DOSE-PAINTED INTENSITY-MODULATED RADIATION THERAPY FOR ANAL CANCER: A MULTI-INSTITUTIONAL REPORT OF ACUTE TOXICITY AND RESPONSE TO THERAPY
Lisa A. Kachnic et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin
Leonard L. Gunderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
Claire Vautravers Dewas et al.
RADIATION ONCOLOGY (2012)
The epidemiology of anal cancer
Andrew E. Grulich et al.
SEXUAL HEALTH (2012)
Efficacy of Cetuximab in Combination with FOLFIRI in a Patient with KRAS Wild-Type Metastatic Anal Cancer
Hanna Barmettler et al.
CASE REPORTS IN ONCOLOGY (2012)
Intensity-Modulated Radiation Therapy Versus Conventional Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal
Jose G. Bazan et al.
CANCER (2011)
Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)
J. Northover et al.
BRITISH JOURNAL OF CANCER (2010)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Cetuximab-Based Treatment of Metastatic Anal Cancer: Correlation of Response with KRAS Mutational Status
Nadine Lukan et al.
ONCOLOGY (2009)
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal - A randomized controlled trial
Jaffer A. Ajani et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: A multicenter experience
Joseph K. Salama et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prevalence of HPV infection among females in the United States
Eileen F. Dunne et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Anal cancer incidence and survival: The surveillance, epidemiology, and end results experience, 1973-2000
LG Johnson et al.
CANCER (2004)
分享论文
